|
Cancer Treatment Centers of America at Midwestern Regional Medical Center Zion, IL 60099 Medicare Provider Number: 140100 |
Free Profile |
Identification and Characteristics
- Last updated 04/23/2012 / Definitions
|
|
Clinical Services
|
|
Joint Commission Accreditation
- Accreditation status licensed from The Joint Commission
- Last updated 02/04/2012 / Definitions and Terms of Use
- Current Status: 01/12/2011 - Accreditation with Full Standards Compliance
Approved Cancer Program
- Approval status provided by The American College of Surgeons (ACS) Commission on Cancer (CoC) Approvals Program.
- See ACS/CoC website for more / Last updated 05/10/2011 / Definitions
- Type: Community Hospital Comprehensive Cancer Program
Inpatient Utilization Statistics by Medical Service
| Number Medicare Inpatients |
Average Length of Stay |
Average Charges |
Medicare Case Mix Index (CMI) |
|
|---|---|---|---|---|
| Cardiology | 16 | 4.50 | $46,821 | 1.1329 |
| Medicine | 100 | 6.18 | $61,798 | 0.9851 |
| Oncology | 75 | 6.59 | $71,506 | 1.3925 |
| Pulmonology | 18 | 5.11 | $54,842 | 1.1543 |
| Surgery | 55 | 10.13 | $109,004 | 2.6136 |
| Urology | 15 | 6.47 | $74,410 | 1.4336 |
| Total | 298 | 6.80 | $72,428 | 1.4751 |
Inpatient Origin for Top 3 Zip Codes
- Medicare Hospital Market Service Area File for calendar year ending 12/31/2010 / Definitions
| ZIP Code of Residence | Discharges | Days of Care | Charges | Discharges Inc/(Dec) | Market Share |
|---|---|---|---|---|---|
| 60099 | 29 | 119 | $1,084,168 | -9.4% | 1.6% |
Outpatient Utilization Statistics by APC
| APC Number |
APC Description | Number Patient Claims |
Average Charge |
Average Cost |
|---|---|---|---|---|
| 9119 | Injection, pegfilgrastim 6mg | 892 | $9,276 | $2,286 |
| 9214 | Bevacizumab injection | 235 | $381 | $94 |
| 0283 | Computed Tomography with Contrast | 2,321 | $1,820 | $282 |
| 9213 | Pemetrexed injection | 88 | $192 | $47 |
| 0412 | IMRT Treatment Delivery | 48 | $1,636 | $382 |
| 0823 | Docetaxel injection | 160 | $120 | $30 |
| 0308 | Non-Myocardial Positron Emission Tomography (PET) imaging | 319 | $5,971 | $925 |
| 0440 | Level V Drug Administration | 1,139 | $750 | $175 |
| 0828 | Gemcitabine hcl injection | 143 | $967 | $238 |
| 9240 | Injection, ixabepilone | 76 | $359 | $88 |
| 1712 | Paclitaxel protein bound | 65 | $51 | $13 |
| 9115 | Zoledronic acid | 323 | $1,233 | $304 |
| 9243 | Bendamustine injection | 28 | $62 | $15 |
| 0849 | Rituximab injection | 36 | $3,425 | $844 |
| 9210 | Palonosetron hcl | 1,166 | $233 | $57 |
| 0437 | Level II Drug Administration | 2,287 | $155 | $38 |
| 9215 | Cetuximab injection | 35 | $317 | $78 |
| 1738 | Oxaliplatin | 66 | $51 | $13 |
| 1613 | Trastuzumab injection | 60 | $540 | $133 |
| 1685 | Darbepoetin alfa, non-esrd | 105 | $15 | $4 |
Beds and Patient Days by Unit
| Available Beds | Inpatient Days | |
|---|---|---|
| HOSPITAL (including swing beds) |
||
| Routine Services | 62 | 9,772 |
| Special Care | 5 | 1,821 |
| Nursery | 0 | 0 |
| Total Hospital | 67 | 11,593 |
Financial Statistics
| $ | % | |
|---|---|---|
| Gross Patient Revenue | 100.0 | |
| Non-Patient Revenue | 0.0 | |
| Total Revenue | ||
| Net Income (or Loss) | -133.9 |
